RBC Europe’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $3.37M | Sell |
22,008
-105
| -0.5% | -$16.1K | 0.16% | 58 |
|
|
2022
Q1 | $3.59M | Sell |
22,113
-674
| -3% | -$109K | 0.15% | 63 |
|
|
2021
Q4 | $3.09M | Sell |
22,787
-7,475
| -25% | -$1.01M | 0.14% | 65 |
|
|
2021
Q3 | $3.26M | Sell |
30,262
-500
| -2% | -$53.9K | 0.13% | 86 |
|
|
2021
Q2 | $3.47M | Buy |
30,762
+375
| +1% | +$42.2K | 0.16% | 85 |
|
|
2021
Q1 | $3.29M | Buy |
30,387
+620
| +2% | +$67.1K | 0.18% | 83 |
|
|
2020
Q4 | $3.19M | Sell |
29,767
-324
| -1% | -$34.7K | 0.18% | 76 |
|
|
2020
Q3 | $2.64M | Sell |
30,091
-12,743
| -30% | -$1.12M | 0.18% | 80 |
|
|
2020
Q2 | $4.21M | Buy |
42,834
+344
| +0.8% | +$33.8K | 0.33% | 50 |
|
|
2020
Q1 | $3.24M | Buy |
42,490
+233
| +0.6% | +$17.8K | 0.32% | 54 |
|
|
2019
Q4 | $3.74M | Buy |
42,257
+330
| +0.8% | +$29.2K | 0.33% | 55 |
|
|
2019
Q3 | $3.17M | Sell |
41,927
-310
| -0.7% | -$23.5K | 0.31% | 57 |
|
|
2019
Q2 | $3.07M | Buy |
42,237
+30
| +0.1% | +$2.18K | 0.31% | 61 |
|
|
2019
Q1 | $3.4M | Buy |
42,207
+870
| +2% | +$70.1K | 0.38% | 54 |
|
|
2018
Q4 | $3.81M | Hold |
41,337
| – | – | 0.5% | 41 |
|
|
2018
Q3 | $3.91M | Sell |
41,337
-60
| -0.1% | -$5.68K | 0.43% | 48 |
|
|
2018
Q2 | $3.84M | Sell |
41,397
-2,955
| -7% | -$274K | 0.45% | 49 |
|
|
2018
Q1 | $4.2M | Buy |
44,352
+2,285
| +5% | +$216K | 0.51% | 45 |
|
|
2017
Q4 | $4.07M | Sell |
42,067
-10
| -0% | -$967 | 0.5% | 44 |
|
|
2017
Q3 | $3.74M | Buy |
+42,077
| New | +$3.74M | 0.49% | 44 |
|